HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Helen of Troy

This article was originally published in The Rose Sheet

Executive Summary

Personal care sales rose 4.8% to $105.3 mil. for the first quarter (ended May 31), the firm reported during a July 10 analyst call. Helen of Troy attributed the performance to new product offerings with higher average unit prices, expanded offerings with current customers, the addition of new domestic customers and "continued growth" in the firm's Latin American territories. Sales also benefited from a 5.9% increase in the grooming segment, which includes hair and skin care lines Brut,Sea Breeze,Vitalis and Condition 3-in-1. Helen of Troy's net sales rose 2.4% to $130.4 mil., while net earnings dropped 36.4% to $6.7 mil. or $0.21 per fully diluted share. Regarding the outlook of personal care, the firm notes early indications of the retail sell-through of higher end personal care products in the mass channel are "encouraging"...

You may also be interested in...

JT Gains World-First Topical JAK Inhibitor Approval

Latest new drug approvals in Japan include the first anywhere for a topical JAK inhibitor and also a marketing clearance for a new contender in the large prostate cancer space.

QUOTED. 27 January 2020. John McKay.

Consultant John McKay encourages device makers to ask questions of the US FDA’s inspection team during a facility audit. Check out his advice here.

The ICER Process: Allergan Engagement Improves Cost Effectiveness Rating For Ubrelvy

ICER president Steve Pearson is ‘cautiously optimistic’ that net pricing for acute migraine treatments will align with benefits once discounts are factored in.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts